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Abstract 
BACKGROUND: The discovery of antiretroviral (ARV) drugs in 1996 led to a shift in the causes of mortality and 
morbidity of patients with HIV/AIDS. Initially, the cause of mortality and morbidity was associated with 
opportunistic infection HIV/AIDS-related complication, but now are more associated with non-AIDS complication 
such as cardiovascular disease. Atherosclerosis is a major cause of cardiovascular disease. The atherosclerosis 
was assessed by measuring carotid intima-media thickness (CIMT) using B mode ultrasound (USG), which is one 
of the diagnostic tools in indicating the presence of atherosclerotic plaque.  
AIM: This study aims to evaluate the ratio of CD4 / CD8 towards carotid intima-media thickness. 
METHODS: Design of study was analytic cross-sectional. This study was conducted in May – July 2017 in HIV 
patients who taken consecutively came to the VCT polyclinic of Sanglah hospital. Statistical analysis used 
Spearman correlation test to evaluate the correlation between the CD4/CD8 ratio and carotid intima-media 
thickness and multiple linear regression to predict carotid intima-media thickness through CD4/CD8 ratio. 
RESULTS: Total from 50 samples, data characteristic were 33 males (66%) and 17 females (34%), mean of age 
30.60 ± 5,58 years, median of CD4/CD8 ratio 0.275 (0.02-1.39) and median of CIMT 0.75 (0.4-1.5) mm. There is 
a strong negative correlation (r = -0.85; p = 0.001) CD4/CD8 ratio with CIMT. The calculation of the prediction of 
carotid intima media thickness can be calculated through the equation Y = 0.727 -0.791 (X1) + 0.012 (X2), where 
X1 is CD4/CD8 ratio and X2 is the age of the patient. 
CONCLUSION: there is a significantly strong negative correlation between the CD4/CD8 ratio and CIMT in HIV 
patient who comes to VCT polyclinic of Sanglah Hospital. The smaller CD4/CD8 ratio, the value of CIMT will be 
thicker, and vice versa. 
 
 
 
 
Introduction 
 
Human Immunodeficiency Virus (HIV) is a 
retrovirus that attacks the human immune system. 
This loss of function causes a progressive immune 
system response disorder, which then develops into 
Acquired Immunodeficiency Syndrome (AIDS). 
Characteristics of this disease in the form of a decline 
in the immune system that causes opportunistic 
infections, secondary neoplasm, and other 
neurological manifestations 
The discovery of antiretroviral drugs (ARVs) in 
1996 is considered one of the successes in medicine 
in controlling HIV infection. The presence of 
antiretroviral drugs causes a shift in the causes of 
morbidity and mortality of patients with HIV/AIDS 
infection. Initially, the causes of morbidity and 
mortality were associated with opportunistic infections 
associated with HIV, but now more morbidity and 
mortality are associated with non-AIDS complications 
such as cardiovascular disease, renal impairment, 
liver disease, neurocognitive disorders, osteoporosis, 
muscle atrophy, and frailty [1]. Pacheco et al., (2009) 
conducted a cohort study in 1538 HIV-infected 
patients and had taken ARVs from 1997-2006, found 
that 226 (14.7%) died during the study, 43.4% had 
non-AIDS-related complications, 37.6% had 
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complications of opportunistic infections. Deaths 
associated with HIV/AIDS infection experienced a 
significant decrease over time (p < 0.01). In the 2005-
2006 period, it was found that non-AIDS-related 
deaths were higher than AIDS-related deaths [2]. 
Cardiovascular disease is an important cause 
of morbidity and mortality in HIV/AIDS patients. 
Patients with HIV/AIDS have a higher risk of having 
myocardial infarction and death due to cardiovascular 
disorders. The mortality rate of cardiovascular events 
in HIV/AIDS patients in Europe and North America 
reached 6.5%-15% [1]. Rates of hospitalization for 
coronary heart disease and acute myocardial 
infarction in HIV positive are higher than HIV negative 
person (6.5% versus 3.8%, p = 0.003, 4.3% versus 
2.9%, p = 0.07) [3].  
Atherosclerosis is a major cause of 
cardiovascular disease. Atherosclerosis in HIV 
patients occurs younger than the general population, 
beginning at < 30 years with an average age of 48 
years. Although HIV infection itself also facilitates 
atherosclerosis. Atherosclerosis associated with 
ageing and its major pathogenesis is the occurrence 
of inflammatory processes. While in HIV patients, 
there is a chronic inflammatory process that affects 
the presence of premature ageing syndrome. 
Therefore, in HIV patients, more easily, the 
occurrence of atherosclerosis than with no HIV 
infection [4], [5], [6]. 
The diagnosis of early atherosclerosis is 
made by measuring the thickness of the carotid 
arteries intima tunica and the presence of 
atherosclerotic plaque. Measurement of Carotid 
intima-media thickness (CIMT) with B-mode 
ultrasonography (USG) is a sensitive and non-
invasive technique for identifying and quantifying 
subclinical vascular disease and evaluating the risk of 
cardiovascular disease. CIMT is significantly 
correlated with the risk of myocardial infarction, 
stroke, death from coronary heart disease, or a 
combination of these. Carotid plaque is defined as a 
focal region in which a CIMT of more than 1.5 mm 
protrudes into the lumen [7].  
Over the past three decades, the number of 
Cluster Differentiation (CD) 4 was used as an 
evaluation of HIV clinical management. In a study 
conducted by Villar et al., (2014), the CD4/CD8 ratio 
could be used as a marker of inflammation and 
immunosenescence and as a predictor of mortality in 
patients with HIV infection. This CD4/CD8 ratio 
indicates immune activation in people with HIV 
infection. The smaller the CD4/CD8 ratio, the higher 
the immune activation. In HIV infection, there will be 
CD4 cell damage that will cause the CD4 value to 
drop dramatically. CD4 cell decline will be 
compensated by continuous CD8 increases. Even 
with the provision of ARVs, slow CD4 cell recovery is 
not necessarily followed by a direct decrease in CD8 
cells so that immune activation occurs continuously. 
This will lead to a smaller CD4/CD8 ratio that 
indicates high chronic inflammatory activity. This 
process of chronic immune activation is associated 
with increased atherosclerosis. The study concluded 
that the ratio of CD4/CD8 inversion determines carotid 
intima-media thickness in patients with HIV infection 
(OR 2.9, CI 95%: 1.2-7.1) [4]. 
Atherosclerosis, which is one of the non-AIDS 
complications, has a major influence on the incidence 
of morbidity and mortality in patients with HIV/AIDS 
[8]. Research on the CD4/CD8 ratio associated with 
atherosclerosis in HIV patients is rare. This research 
aims to role out the association of atherosclerosis 
events and to determine the role of CD4/CD8 ratio in 
the occurrence of atherosclerosis (in this case 
measured by CIMT using USG) in HIV outpatients at 
tropical disease and infection polyclinic Sanglah 
General Hospital, Bali-Indonesia.  
 
 
Methods 
 
This study was an observational study with 
cross-sectional analytic design to determine the 
correlation between CD4/CD8 ratio with carotid 
intima-media thickness as a marker of atherosclerosis 
in HIV patients. The research was conducted in 
tropical disease and infection outpatient clinic Sanglah 
General Hospital, Bali-Indonesia in May 2017 until 
July 2017. The subjects of this study were recruited 
through consecutive sampling to be fulfilled the 
desired number of samples. The inclusion criteria in 
this study were HIV outpatient care in tropical disease 
and infection polyclinic and patients aged between 18-
40 years. Exclusion criteria in this study are HIV 
patient with diabetes mellitus, hypertension, 
hypercholesterolemia, hypertriglyceridemia, 
malignancy, coronary heart disease, chronic renal 
failure, obesity, pregnancy, and cocaine users. The 
thickness of the Intima-Media (CIMT) of the carotid 
artery is the value of CIMT as measured by USG B-
mode Ultrasound Logic-5 aircraft with a linear 
transducer frequency of 7.5 Mhz. The examination 
includes the thickness of the tunica intima-media of 
the carotid artery and the presence of atherosclerotic 
plaque. Measurements of CMT are performed at one 
point on both sides of the carotid artery, expressed in 
millimetres. The point is in the communist carotid 
artery (10 mm before the carotid bulb). The 
measurements of CIMT in all samples will be 
performed by one consultant radiology specialist. The 
CD4/CD8 ratio was a comparison of CD4 lymphocyte 
count cell count, and CD8 T lymphocyte counts 
examined using flow cytometry (Becton Dickinson 
(BD) FASCount System. 
The data were analysed using Spearman 
correlation test to evaluate the correlation between 
CIMT with CD4/CD8 ratio and linear regression 
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analysis to assess the effect and pure relationship of 
CD4/CD8 ratio to CIMT after controlling confounding 
variables by analysis. 
 
 
Results 
 
The study involved as many as 50 HIV 
patients who came to the tropical disease and 
infection polyclinic at Sanglah General Hospital, Bali-
Indonesia. The complete subject characteristics can 
be seen in Table 1. 
Table 1: Subject characteristics 
Subject Characteristics  Frequency 
Gender   
Male  33 (66%) 
Female 17 (34%) 
Age (Mean ± SD) 30.60 ± 5.58 
BMI (kg/m2) (Mean ± SD) 20.52 ± 2.40 
Smoking status  
No  34 (68%) 
Yes 16 (32%) 
Smoking duration (years), median (min-max) 0 (0-20) 
HBsAg Status  
Negatif 50 (100%) 
Reactif 0 (0%) 
Anti HCV Status  
Negatif 49 (98%) 
Reactif 1 ( 2%) 
TBC status   
Negatif 42 (84%) 
On treatment  5 (10%) 
End of treatment 3 (6%) 
Combination therapy  
TDF/3TC/EFV 26 (52%) 
AZT/3TC/NEV 7 (14%) 
TDF/3TC/NEV 2 (4%) 
AZT/3TC/EFV 2 (4%) 
AZT/3TC/aluvia 1 (2%) 
TDF/3TC/aluvia 3 (6%) 
Naif  9 (18%) 
ARV therapy duration (month), median (min-max) 12 (0-120) 
CD4/CD8 ratio 0.275 (0.02- 1.39) 
CD4/CD8 < 1 47 (94%) 
CD4/CD8 ≥ 1 3 (6%) 
CIMT (mm), median (min-max) 0.75 (0.4-1.5) 
 
Based on Table 1, the most gender in the 
study subjects were men as many as 33 people 
(66%), the mean age in the study subjects was 30.60 
± 5.58 years, the mean body mass index in the study 
subjects was 20.52 ± 2.40 kg/m
2
, all patient without 
comorbidity of Hepatitis B, only one patient with 
hepatitis C comorbidity, based on TB status 42 (84%) 
of study subjects had negative TB status, based on 
antiretroviral therapy a combination of TDF/3TC/EFV 
is the most commonly used regimen as mucg as 26 
people (52%), based on the duration of antiretroviral 
treatment there was a range of ARVs in patients 
ranging from 0 to 120 months, based on CD4/CD8 
ratios, the most is < 1 as much as 47 people (94%), 
CIMT thickness ranges from 0.4 to 1.5 mm. The 
correlation between CD4/CD8 ratio and CIMT can be 
seen in Table 2. 
Table 2: Correlation between CD4/CD8 ratio with CIMT 
Variable Median (interquartil 
range) 
r p-value 
CD4/CD8 ratio 0.275 (0.32)  
-0.85 
 
0.001* CIMT  0.755 (0.4) 
*significant (p < 0.05). 
Based on Table 2, the correlation between 
CD4/CD8 ratio and carotid artery intima-media 
thickness, with correlation coefficient of r = -0.850 and 
p-value = 0.001. This indicates that the CD4/CD8 ratio 
has a strong negative correlation that is significant 
against carotid artery intima-media thickness. So, it 
can be interpreted that any increase in CD4/CD8 ratio 
will be followed by decreased CIMT. Multiple linear 
regression analysis of CD4/CD8 ratio with CIMT and 
control of confounding factors can be seen in Table 3. 
Table 3: Multiple linear regression on CD4/CD8 ratio with CIMT 
and confounding factors 
Variable β R-square CI 95% p-value 
CD4/CD8 ratio -0.791 0.561 -0.99 – (-0.592) < 0.001 
Age 0.012 0.002 – 0.022 0.022 
Combination of ARV 0.011 -0.013 – 0.035 0.356 
Duration of smoking  0.005 -0.007 – 0.017 0.401 
Gender  0.019 -0.118 – 0.156 0.781 
BMI 0.000 -0.025 – 0.026 0.972 
Constant 0.727 0.411 – 1.042 < 0.001 
 
Based on Table 3, after multivariate analysis 
with multiple linear regression on independent 
variables, the effect of CD4 / CD8 ratio and other 
confounding variables on CIMT, the variable that 
proved to influence CIMT is the ratio of CD4 / CD8 
and patient age. 
The coefficient β ratio of CD4 / CD8 ratio (β1)-
0,791 means that every 1 point increase of CD4 / CD8 
ratio followed by a decrease of CIMT equal to 0,791 
mm, coefficient β of age (β2) 0,012 meaning that 
every 1-year-old growth will be followed by CIMT 
increase equal to 0,012 mm. From the result of 
multivariate analysis with multiple linear regression 
with the value of β 0 that is 0,727 could be interpreted 
as an equation formula as follows: 
Y = 0.727 - 0.791 (X1) + 0.012 (X2) 
Y: Carotid intima-media thickness 
X1: CD4/CD8 ratio 
X2: patient age. 
The value of discrimination through R-square 
result is 0.561, which means that the formula obtained 
can explain CIMT influenced by CD4 / CD8 ratio and 
age is 56,1% while the rest 43,9% is explained by 
another variable outside the research studied variable. 
 
 
Discussion 
 
The result of this study found a strong 
negative correlation between the CD4/CD8 ratio with 
CIMT. These findings are supported by research by 
Villar et al., (2013) that the CD4/CD8 ratio is 
correlated with CIMTwith r = -0.2, p = 0.037 [8]. 
Another interesting point with different methods 
obtained from Morrel et al. (2016) research found that 
the progression of carotid artery intima-media 
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thickness was inversely related to CD4/CD8 ratio with 
OR = 0.283; CI 95% (0.099-0.809), p = 0.019 [9]. 
Another research conducted by Lo et al. (2010) found 
that the CD4/CD8 ratio was negatively correlated with 
the volume of atherosclerotic plaque. Also, Lo and 
colleagues concluded that the CD4/CD8 ratio was 
stronger than either CD4 cell count or viral load 
versus plaque volume [10]. Studies conducted in New 
York concluded that low CD4 cell count was a major 
risk factor for atherosclerosis in HIV-infected patients. 
Compared with non-HIV-infected patients, the 
prevalence risk ratio of atherosclerosis in HIV patients 
with CD4 cell count < 200 cells / mm3 was 2 (95% CI: 
1.22-3.28) in women and 1.74 (CI 95%; 1.04-2.93) in 
men [11]. A low CD4 value will result in a low 
CD4/CD8 ratio value, and this is by our study, which 
will lead to increased carotid intima-media thickness in 
HIV-infected patients. In contrast, higher CD4 values 
will result in a higher CD4/CD8 ratio. A high CD4/CD8 
ratio indicates a low inflammatory factor and is 
associated with a decrease in the incidence of 
atherosclerosis in HIV-infected patients. 
The CD4/CD8 ratio shows the level of 
strength of the immune system. A lower CD4/CD8 
ratio indicates a higher rate of chronic inflammatory 
activation. Most patients with HIV infection have a low 
CD4/CD8 ratio, even patients who have received 
ARVs often fail to achieve normal CD4/CD8 ratios, 
despite achieving normal CD4 cell counts. This is due 
to immunological abnormalities in the same HIV 
patients encountered in elderly patients, including 
skewed T cell phenotype, CD8 cell activation (CD38 
+), CD8 cell senescence (CD28- and CD 57 + CD28-). 
This immune activation considered a major factor in 
premature ageing in HIV patients, results in an 
immunocultural phenotype. CD8 increases are 
continuous, regardless of whether or not there is a 
CD4 increase. However, CD8, which has increased 
and activated, is CD8, which has lost its full function 
[9], [12]. CD8 cell activation contributes to vascular 
damage will mediate the occurrence of apoptosis of 
macrophages, smooth muscle cells, endothelial cells 
which subsequently lead to the formation of necrotic 
nuclei which is the forerunner to the formation of 
atherosclerotic plaque [13]. HIV-infected patients with 
higher CRP levels, high CD8 cell activation, high T-
cell response to CMV was independently associated 
with a carotid increase in carotid intima-media 
thickness of HIV patients [11]. 
In this study, multivariate analysis of 
CD4/CD8 ratio and confounding variables were age, 
sex, BMI, duration of smoking and combination of 
ARV. After gradual multivariate analysis, it was found 
that CD4/CD8 ratio and age influenced carotid artery 
intima-media thickness in this study subjects. From 
the equation formula obtained is: Y = 0.727 -0.791 
(X1) + 0.012 (X2), that the increase of CIMT in HIV-
infected patients is influenced by the smaller ratio of 
CD4/CD8 and increasing age. This is by previous 
research results stating the role of CD4/CD8 ratio 
affects the occurrence of carotid artery intima-media 
thickening [8], [9]. In this study, age also affects the 
thickness of the carotid artery intima-media layer. Age 
can independently contribute to the development of 
cardiovascular disease. Every decade of age is 
associated with about twice the increased risk of 
cardiovascular disease (OR per decade of age, i.e., 
2.14, 1.80, and 2.33 for atherosclerosis, carotid 
stenosis, and abdominal aortic aneurysm) [15]. This is 
also supported by Morell's et al., (2016) study with 96 
HIV-infected patients it was found that CIMTwas 
significantly associated with age (r = 0.497; p < 0.001) 
[9]. 
Another study conducted by Bakar et al. 
(2010) concluded that HIV patients with ARV 
treatment compared with no treatment had a lower 
risk of cardiovascular disease. The earlier the 
treatment, the risk of cardiovascular disease will be 
smaller. Early ARV treatment may increase CD4 cell 
counts faster to improve CD4/CD8 ratios. An increase 
in CD4/CD8 ratio will decrease the inflammatory rate 
that has implications for the small incidence of 
atherosclerosis [14]. 
The limitation of this study is the data taken at 
a time, so it is difficult to determine the cause and 
effect relationship. Furthermore, this study was unable 
to monitor how much the effect of CD4/CD8 ratio 
changes on carotid artery CIMT plaque changes. 
In conclusion, there is a negative correlation 
between CD4/CD8 ratio with carotid intima-media 
thickness in HIV/AIDS infected patients in tropical 
disease and infection polyclinic at Sanglah General 
Hospital, Bali-Indonesia. The ratio of CD4/CD8 and 
age is the most important factor in the occurrence of 
non-AIDS complications, specifically the occurrence of 
atherosclerotic plaque. 
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